These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11099249)

  • 1. Plasminogen-enriched pulse-spray thrombolysis with tPA: further developments.
    Bookstein JJ; Bookstein FL
    J Vasc Interv Radiol; 2000; 11(10):1353-62. PubMed ID: 11099249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmented pulse-spray thrombolysis with tPA by early pulsed intrathrombic plasminogen enrichment.
    Lim GM; Bookstein JJ
    J Vasc Interv Radiol; 1998; 9(4):618-25. PubMed ID: 9684833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmented experimental pulse-spray thrombolysis with tissue plasminogen activator, enabling dose reduction by one or more orders of magnitude.
    Bookstein JJ; Bookstein FL
    J Vasc Interv Radiol; 2000 Mar; 11(3):299-303. PubMed ID: 10735423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulse-spray thrombolysis with reteplase: optimization and comparison with tPA in a rabbit model.
    Bookstein JJ; Bookstein FL
    J Vasc Interv Radiol; 2001 Nov; 12(11):1319-24. PubMed ID: 11698632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of intrathrombic administration of prostaglandin E1 during pulse-spray thrombolysis with tissue-type plasminogen activator in experimental thrombosis.
    Valji K; Bookstein JJ
    Radiology; 1993 Mar; 186(3):873-6. PubMed ID: 8430201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of adjunctive intrathrombic heparin with pulse spray thrombolysis in rabbit inferior vena cava thrombosis.
    Valji K; Bookstein JJ
    Invest Radiol; 1992 Nov; 27(11):912-7. PubMed ID: 1464509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of a direct thrombin inhibitor (argatroban) during pulse-spray thrombolysis in experimental thrombosis.
    Valji K; Arun K; Bookstein JJ
    J Vasc Interv Radiol; 1995; 6(1):91-5. PubMed ID: 7703589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasound-facilitated thrombolysis using tissue-plasminogen activator-loaded echogenic liposomes.
    Tiukinhoy-Laing SD; Huang S; Klegerman M; Holland CK; McPherson DD
    Thromb Res; 2007; 119(6):777-84. PubMed ID: 16887172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulsed-high intensity focused ultrasound enhanced tPA mediated thrombolysis in a novel in vivo clot model, a pilot study.
    Stone MJ; Frenkel V; Dromi S; Thomas P; Lewis RP; Li KC; Horne M; Wood BJ
    Thromb Res; 2007; 121(2):193-202. PubMed ID: 17481699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retroviral gene transfer of tissue-type plasminogen activator targets thrombolysis in vitro and in vivo.
    Gong YS; Zhang KL; Jiang XG; Wang ZW; Sun ZQ; Cai J
    Gene Ther; 2007 Nov; 14(21):1537-42. PubMed ID: 17728795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasound-enhanced thrombolytic effect of tissue plasminogen activator-loaded echogenic liposomes in an in vivo rabbit aorta thrombus model--brief report.
    Laing ST; Moody M; Smulevitz B; Kim H; Kee P; Huang S; Holland CK; McPherson DD
    Arterioscler Thromb Vasc Biol; 2011 Jun; 31(6):1357-9. PubMed ID: 21441137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examining the Influence of Low-Dose Tissue Plasminogen Activator on Microbubble-Mediated Forward-Viewing Intravascular Sonothrombolysis.
    Goel L; Wu H; Kim H; Zhang B; Kim J; Dayton PA; Xu Z; Jiang X
    Ultrasound Med Biol; 2020 Jul; 46(7):1698-1706. PubMed ID: 32389332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative thrombolytic properties of tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (u-PA) and K1K2Pu (a t-PA/u-PA chimera) in a combined arterial and venous thrombosis model in the dog.
    Lu HR; Wu Z; Pauwels P; Lijnen HR; Collen D
    J Am Coll Cardiol; 1992 May; 19(6):1350-9. PubMed ID: 1342779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of intrathecally administered urokinase, tissue-type plasminogen activator, and combination of urokinase and lysine-plasminogen for clot lysis after experimental subarachnoid hemorrhage in dogs.
    Kajimoto Y; Ohta T; Kuroiwa T
    Neurosurgery; 1997 Mar; 40(3):572-7. PubMed ID: 9055298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombolysis with low dose tissue plasminogen activator.
    Doyle E; Britto J; Freeman J; Munro F; Morton NS
    Arch Dis Child; 1992 Dec; 67(12):1483-4. PubMed ID: 1489229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombosed hemodialysis grafts: lyse and wait with tissue plasminogen activator or urokinase compared to mechanical thrombolysis with the Arrow-Trerotola Percutaneous Thrombolytic Device.
    Vogel PM; Bansal V; Marshall MW
    J Vasc Interv Radiol; 2001 Oct; 12(10):1157-65. PubMed ID: 11585881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulse-spray pharmacomechanical thrombolysis of thrombosed hemodialysis access grafts: long-term experience and comparison of original and current techniques.
    Valji K; Bookstein JJ; Roberts AC; Oglevie SB; Pittman C; O'Neill MP
    AJR Am J Roentgenol; 1995 Jun; 164(6):1495-500; discussion 1501-3. PubMed ID: 7754901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxygen radical scavenging agents as adjuvant therapy with tissue plasminogen activator in a canine model of coronary thrombolysis.
    Przyklenk K; Kloner RA
    Cardiovasc Res; 1993 Jun; 27(6):925-34. PubMed ID: 8221780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombolytic efficacy of tissue plasminogen activator-loaded echogenic liposomes in a rabbit thrombus model.
    Laing ST; Moody MR; Kim H; Smulevitz B; Huang SL; Holland CK; McPherson DD; Klegerman ME
    Thromb Res; 2012 Oct; 130(4):629-35. PubMed ID: 22133272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An activated-platelet-sensitive nanocarrier enables targeted delivery of tissue plasminogen activator for effective thrombolytic therapy.
    Huang Y; Yu L; Ren J; Gu B; Longstaff C; Hughes AD; Thom SA; Xu XY; Chen R
    J Control Release; 2019 Apr; 300():1-12. PubMed ID: 30807804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.